Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* having clinical AD diagnosis according to the NINCDS-ADRDA (National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association) criteria~* being 60 years and older~* having Clinical Dementia Rating Scale (CDR) scores 1 or 2~* living independently~Exclusion Criteria:~* not being able to walk independently,~* having physical disabilities,~* having a history of alcohol / substance abuse,~* having head trauma~* having epileptic seizures

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TMS group (Type: EXPERIMENTAL): In the TMS group (n=10) rTMS was applied to the bilateral dorsolateral prefrontal cortex (DLPFC) at 20 Hz, for 5 consecutive days per week for over 2 weeks (totally 10 sessions) in addition to the pharmacological treatment.
- AE group (Type: EXPERIMENTAL): AE group (n=9) received a moderate- intensity aerobic exercise program lasting 50 minutes per session, 5 consecutive days per week for over 2 weeks (totally 10 sessions) in addition to the pharmacological treatment.
- Control group (Type: ACTIVE_COMPARATOR): No additional intervention was given to the patients in the control group (n=8) and participants were only treated pharmacologically.

Based on this trial design, predict the completion outcome and termination type (if applicable).